Waters Corporation stock (US9418481035): valuation metrics in focus after recent product news

Waters Corporation shares on the NYSE remain in focus for investors after recent product and regulatory news, prompting a closer look at current valuation metrics and how the life sciences tools provider is positioned in the United States and abroad.

Waters Corporation shares on the New York Stock Exchange continue to trade actively after a series of recent product and regulatory updates in the United States, keeping attention on how the life sciences tools provider is valued in its home market.

The stock traded at USD 377.22 on 06/05/2026 on the NYSE under the ticker WAT, according to MarketBeat as of 06/05/2026.

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Waters Corp
• Sector/industry: Life sciences tools and services
• Headquarters/country: Milford, United States
• Core markets: Americas, Europe, Asia
• Key revenue drivers: Analytical instruments, mass spectrometry systems, chromatography consumables, and related services
• Home exchange/listing venue: NYSE (WAT)
• Trading currency: USD

Waters Corporation: core business model

Waters Corporation focuses on providing laboratories with chromatography, mass spectrometry, and related analytical workflow solutions that generate recurring revenue from instruments, consumables, and services across pharmaceutical, biopharma, and industrial customers.

Valuation metrics and multiples for Waters Corporation

Investors in the United States often benchmark Waters Corporation against other life sciences tools companies by looking at earnings-based multiples and market capitalization data alongside the companys most recent financial results.

Waters Corporation reported first-quarter 2026 results on 05/07/2026, stating that it generated approximately USD 802 million in net sales and diluted earnings per share of USD 3.05 for the period ended 03/31/2026, according to its Q1 2026 press release dated 05/07/2026, as reported by Reuters as of 05/07/2026.

Based on the NYSE closing price of USD 377.22 on 06/05/2026 and the latest available trailing twelve-month diluted earnings per share figure of roughly USD 11.80 cited in summary data for the company, the shares would trade at a price-to-earnings ratio of around 32 as of 06/05/2026, according to calculations using data compiled by MarketBeat as of 06/05/2026.

With a recent market capitalization of about USD 37.3 billion as of 06/05/2026, Waters Corporation is positioned as a large player in the global analytical instruments market, which some investors compare to peers in life sciences tools for relative valuation, according to overview data presented by Simply Wall St in an article dated 06/01/2026 citing a market cap of approximately USD 37.29 billion for the company as of late May 2026.

While Waters Corporation does not currently emphasize a cash dividend, the companys valuation profile is primarily assessed through growth in earnings and cash flow from its instruments and consumables business rather than yield, which is consistent with many US-listed life sciences tools companies in similar stages of growth.

Conclusion

Waters Corporation remains closely watched on the NYSE as investors balance recent operational updates with the companys current earnings profile and valuation multiples.

The combination of a large market capitalization, exposure to global demand for analytical instruments, and a focus on earnings growth rather than dividends means valuation metrics such as the price-to-earnings ratio and cash generation will likely remain central to how the stock is assessed over time.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.